Amneal Pharmaceuticals, Inc. (AMRX)

Solvency & Capital Structure

Total Debt

$2.79B

Net Debt

$2.66B

Amneal Pharmaceuticals, Inc. currently has $2.79B in total debt. Net debt is $2.66B after cash offsets.

Financial Fundamentals

AMRX • Quarterly Data • 5Y View

Date	Total Debt ($B)	Cash & Inv. ($B)	Net Debt ($B)	Total Assets	Debt/Assets
2026-06-30	2.79	0.13	2.66	3.78	73.9%
2026-03-31	2.70	0.20	2.50	3.54	76.2%
2025-12-31	2.74	0.31	2.43	3.68	74.4%
2025-09-30	2.69	0.20	2.48	3.60	74.6%
2025-06-30	2.58	0.08	2.50	3.42	75.4%
2025-03-31	2.58	0.06	2.52	3.37	76.7%
2024-12-31	2.59	0.11	2.48	3.50	74.1%
2024-09-30	2.64	0.07	2.57	3.46	76.4%
2024-06-30	2.73	0.05	2.68	3.51	77.6%
2024-03-31	2.75	0.05	2.70	3.46	79.4%
2023-12-31	2.75	0.09	2.66	3.47	79.2%
2023-09-30	2.80	0.09	2.71	3.69	76.1%
2023-06-30	2.86	0.11	2.75	3.70	77.2%
2023-03-31	2.85	0.15	2.71	3.63	78.7%
2022-12-31	2.85	0.03	2.82	3.80	74.9%
2022-09-30	2.86	0.09	2.77	3.87	73.8%
2022-06-30	2.90	0.09	2.81	4.04	71.7%
2022-03-31	2.87	0.21	2.65	3.89	73.7%
2021-12-31	2.89	0.25	2.64	3.94	73.3%
2021-09-30	2.91	0.30	2.61	3.97	73.3%
2021-06-30	2.95	0.28	2.67	4.02	73.3%
2021-03-31	2.92	0.45	2.47	3.96	73.7%
2020-12-31	3.00	0.34	2.66	4.01	74.9%
2020-09-30	2.96	0.28	2.68	4.04	73.3%
2020-06-30	2.97	0.27	2.71	4.06	73.3%
2020-03-31	3.28	0.41	2.87	4.39	74.7%
2019-12-31	2.77	0.15	2.62	3.67	75.6%
2019-09-30	2.77	0.21	2.56	3.70	74.9%
2019-06-30	2.78	0.05	2.73	4.26	65.3%
2019-03-31	2.79	0.06	2.73	4.38	63.7%
2018-12-31	2.69	0.21	2.48	4.35	61.8%
2018-09-30	2.87	0.17	2.71	4.58	62.7%
2018-06-30	2.78	0.06	2.72	4.54	61.2%
2018-03-31	1.48	0.05	1.43	1.36	109.0%
2017-12-31	1.48	0.07	1.41	1.34	110.6%
2017-09-30	1.46	0.02	1.44	1.24	118.1%
2017-03-31	0.00	0.03	-0.03Net Cash	0.00	—
2016-12-31	1.20	0.03	1.17	1.22	98.2%